CN Patent

CN119040247B — 乳酸多韦替尼在上调细胞中乳铁蛋白表达中的应用

Assigned to Beijing Sanyuan Foods Co Ltd · Expires 2025-02-18 · 1y expired

What this patent protects

本发明提供了乳酸多韦替尼在上调细胞中乳铁蛋白表达中的应用，涉及生物技术领域，首次提出了乳酸多韦替尼在上调细胞中促进乳铁蛋白表达中的应用，实验证明，乳酸多韦替尼能够激活LF启动子，可显著增强细胞中乳铁蛋白的表达量，促进乳铁蛋白合成。

USPTO Abstract

本发明提供了乳酸多韦替尼在上调细胞中乳铁蛋白表达中的应用，涉及生物技术领域，首次提出了乳酸多韦替尼在上调细胞中促进乳铁蛋白表达中的应用，实验证明，乳酸多韦替尼能够激活LF启动子，可显著增强细胞中乳铁蛋白的表达量，促进乳铁蛋白合成。

Drugs covered by this patent

Patent Metadata

Patent number
CN119040247B
Jurisdiction
CN
Classification
—
Expires
2025-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Sanyuan Foods Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.